Request for Covid-19 Impact Assessment of this Report
The regional analysis of global Tumor Ablation Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing acceptance of tumor ablation products due to rising prevalence of cancer, surging inclination of patients towards minimally invasive procedures and increasing government funding for cancer research in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as improving healthcare infrastructure, increasing number of cancer patients and growing government assistance programs to reduce cancer incidence would fuel-up the adoption of Tumor Ablation in the Asia-Pacific region.
Major market player included in this report are:
Medtronic, PLC.
Angiodynamics, Inc.
Healthtronics, Inc.
Galil Medical, Inc.
Boston Scientific Corporation
Neuwave Medical, Inc.
Edap Tms S.A.
Mermaid Medical A/S
Sonacare Medical, LLC
Misonix, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Radiofrequency
Microwave
Cryoablation
Others
By Mode of Treatment:
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation
By Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Tumor Ablation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Tumor Ablation Market, by Technology, 2017-2026 (USD Million)
1.2.2. Tumor Ablation Market, by Mode of Treatment, 2017-2026 (USD Million)
1.2.3. Tumor Ablation Market, by Application, 2017-2026 (USD Million)
1.2.4. Tumor Ablation Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tumor Ablation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tumor Ablation Market Dynamics
3.1. Tumor Ablation Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Tumor Ablation Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Tumor Ablation Market, by Technology
5.1. Market Snapshot
5.2. Global Tumor Ablation Market by Technology, Performance - Potential Analysis
5.3. Global Tumor Ablation Market Estimates & Forecasts by Technology 2016-2026 (USD Million)
5.4. Tumor Ablation Market, Sub Segment Analysis
5.4.1. Radiofrequency
5.4.2. Microwave
5.4.3. Cryoablation
5.4.4. Others
Chapter 6. Global Tumor Ablation Market, by Mode of Treatment
6.1. Market Snapshot
6.2. Global Tumor Ablation Market by Mode of Treatment, Performance - Potential Analysis
6.3. Global Tumor Ablation Market Estimates & Forecasts by Mode of Treatment, 2016-2026 (USD Million)
6.4. Tumor Ablation Market, Sub Segment Analysis
6.4.1. Surgical Ablation
6.4.2. Laparoscopic Ablation
6.4.3. Percutaneous Ablation
Chapter 7. Global Tumor Ablation Market, by Application
7.1. Market Snapshot
7.2. Global Tumor Ablation Market by Application, Performance - Potential Analysis
7.3. Global Tumor Ablation Market Estimates & Forecasts by Application, 2016-2026 (USD Million)
7.4. Tumor Ablation Market, Sub Segment Analysis
7.4.1. Liver Cancer
7.4.2. Lung Cancer
7.4.3. Kidney Cancer
7.4.4. Others
Chapter 8. Global Tumor Ablation Market, Regional Analysis
8.1. Tumor Ablation Market, Regional Market Snapshot
8.2. North America Tumor Ablation Market
8.2.1. U.S. Tumor Ablation Market
8.2.1.1. Technology breakdown estimates & forecasts, 2016-2026
8.2.1.2. Mode of Treatment breakdown estimates & forecasts, 2016-2026
8.2.1.3. Application breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Tumor Ablation Market
8.3. Europe Tumor Ablation Market Snapshot
8.3.1. U.K. Tumor Ablation Market
8.3.2. Rest of Europe Tumor Ablation Market
8.4. Asia-Pacific Tumor Ablation Market Snapshot
8.4.1. China Tumor Ablation Market
8.4.2. India Tumor Ablation Market
8.4.3. Japan Tumor Ablation Market
8.4.4. Rest of Asia Pacific Tumor Ablation Market
8.5. Latin America Tumor Ablation Market Snapshot
8.5.1. Brazil Tumor Ablation Market
8.5.2. Mexico Tumor Ablation Market
8.6. Rest of The World Tumor Ablation Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Medtronic, PLC.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject To Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Angiodynamics, Inc.
9.2.3. Healthtronics, Inc.
9.2.4. Galil Medical, Inc.
9.2.5. Boston Scientific Corporation
9.2.6. Neuwave Medical, Inc.
9.2.7. Edap Tms S.A.
9.2.8. Mermaid Medical A/S
9.2.9. Sonacare Medical, LLC
9.2.10. Misonix, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL TUMOR ABLATION MARKET
TABLE 3. GLOBAL TUMOR ABLATION MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)
TABLE 8. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY MODE OF TREATMENT 2016-2026 (USD MILLION)
TABLE 9. GLOBAL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 23. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 26. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 29. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 32. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 35. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. GLOBAL TUMOR ABLATION MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. GLOBAL TUMOR ABLATION MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 38. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. U.S. TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 44. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. CANADA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. UK TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. GERMANY TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 59. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 60. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 61. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 62. ROE TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 63. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 64. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 65. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 66. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 67. CHINA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 68. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 69. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 70. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 71. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 72. INDIA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 73. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 74. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 75. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 76. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 77. JAPAN TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 78. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 79. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 80. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 81. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 82. ROAPAC TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 83. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 84. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 85. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 86. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 87. BRAZIL TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 88. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 89. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 90. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 91. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 92. MEXICO TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 93. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 94. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 95. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 96. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 97. ROLA TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 98. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 99. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 100. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 101. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 102. ROW TUMOR ABLATION MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...